Streetbeat News

Price Targets

TMO

HSBC analyst Rajesh Kumar has initiated coverage on Thermo Fisher Scientific (NYSE:TMO) with a Buy rating and set a price target of $610.

Portfolio Pulse from Benzinga Newsdesk

December 18, 2023 | 1:05 pm

PRST

Jefferies analyst Samad Samana has initiated coverage on Presto Automation (NASDAQ:PRST) with a Hold rating and set a price target of $0.62.

Portfolio Pulse from Benzinga Newsdesk

December 18, 2023 | 1:03 pm

ARDX

Raymond James analyst Steven Seedhouse has initiated coverage on Ardelyx (NASDAQ:ARDX) with a Strong Buy rating and set a price target of $12.

Portfolio Pulse from Benzinga Newsdesk

December 18, 2023 | 1:01 pm

DOOR

Masonite International (NYSE:DOOR) has received 6 analyst ratings in the last quarter, with an average price target of $101.33, representing an implied upside from the current price of $96.00. This average price target is a 17.48% decrease from the previous target of $122.80. The ratings consist of 2 bullish, 1 somewhat bullish, and 3 indifferent, with no bearish ratings. Analysts typically review stocks quarterly or after major company updates, basing their opinions on financial forecasts, company performance, and industry trends.

Portfolio Pulse from Benzinga Insights

December 18, 2023 | 1:01 pm

SHOP

Over the last quarter, Shopify (NYSE:SHOP) received a mix of analyst ratings, with 2 bullish, 3 somewhat bullish, 6 indifferent, 1 somewhat bearish, and 1 bearish. The average 12-month price target for Shopify is $68.08, ranging from $55.00 to $100.00. This target has increased by 1.04% in the past month. Analyst ratings are based on financial analysis and are subject to human error.

Portfolio Pulse from Benzinga Insights

December 18, 2023 | 1:00 pm

TENB

Tenable Holdings (NASDAQ:TENB) has received mixed analyst ratings in the last quarter, with 2 bullish, 3 somewhat bullish, and 5 indifferent ratings. The average 12-month price target among 10 analysts is $48.6, which is a decrease of 5.45% from the previous target of $51.40. Analysts rate stocks based on future earnings potential and company risk profile, typically updating their ratings quarterly or after significant company events.

Portfolio Pulse from Benzinga Insights

December 18, 2023 | 1:00 pm

ABBV

Over the last quarter, AbbVie (NYSE:ABBV) received 8 analyst ratings, with an average 12-month price target of $174.5, a high of $196.00, and a low of $150.00. The current average price target represents a 1.52% decrease from the previous average of $177.20. The ratings included 1 bullish, 5 somewhat bullish, and 2 indifferent, with no bearish or somewhat bearish ratings. Analysts typically review stocks quarterly or after major company updates, considering financial performance and market risks.

Portfolio Pulse from Benzinga Insights

December 18, 2023 | 1:00 pm

ALLK

Over the past 3 months, 5 Wall Street analysts have published their opinions on Allakos (NASDAQ:ALLK), with 1 bullish, 3 somewhat bullish, and 1 somewhat bearish rating. No bearish or indifferent ratings were given. The average 12-month price target for Allakos is $7.7, with a high of $11.00 and a low of $1.50. This target has increased by 2.67% over the past month. Analysts typically review stocks quarterly and provide ratings that influence stock performance.

Portfolio Pulse from Benzinga Insights

December 18, 2023 | 1:00 pm

UNH

In the last quarter, UnitedHealth Group (NYSE:UNH) received 12 analyst ratings, with an average 12-month price target of $573.33, a high of $640.00, and a low of $480.00. The distribution of ratings was 2 bullish, 7 somewhat bullish, 2 indifferent, and 1 somewhat bearish, with no bearish ratings. The average price target has increased by 1.68% over the past month.

Portfolio Pulse from Benzinga Insights

December 18, 2023 | 1:00 pm

CCS

Wedbush analyst Jay McCanless has downgraded Century Communities (NYSE:CCS) from Outperform to Neutral and set a price target of $81.

Portfolio Pulse from Benzinga Newsdesk

December 18, 2023 | 12:59 pm